Hi Davisite,
You are correct in saying about the European approvals.
1 of my other bio company, had EMA in 2017 and then last year received the new regulations approval.
While this company is not a drug company, yet it is a Medical Device, which had to re-apply again.
Below is a snippet of the announcement.
IMHO.
Regards
Rossi70
IND before Australian ethics?, page-13
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
-0.050(3.17%) |
Mkt cap ! $259.9M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.59 | $1.51 | $174.6K | 113.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2372 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 141 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |